Happy Thanksgiving from our Sterling family to yours! #WeAreSterling
Sterling Pharma Solutions
Pharmaceutical Manufacturing
Dudley, Cramlington 21,047 followers
Sterling Pharma Solutions is a leading provider of API services to the pharmaceutical industry.
About us
Sterling Pharma Solutions is a global contract development and manufacturing organisation (CDMO) with 50+ years’ experience in providing small molecule API development and manufacturing services to the pharmaceutical industry, specialising in handling challenging chemistries. Sterling manages the most complex API and API intermediate challenges from proof-of-concept to commercial manufacture, as well as Antibody Drug Conjugate (ADC) development and manufacturing services. Sterling believes that while science can be complex, partnerships should be simple. That’s why they have redefined the CDMO experience, marked by transparency, collaboration and trust; a Partnership Development and Manufacturing Organisation (PDMO®). Sterling has six facilities across the UK, USA and Europe, employing 1,350+ people, including in Cramlington and Newcastle, UK; Deeside, Wales; Cork, Ireland, as well as North Carolina and Wisconsin in the US. Find out more: www.sterlingpharmasolutions.com/sterling-facilities
- Website
-
http://www.sterlingpharmasolutions.com
External link for Sterling Pharma Solutions
- Industry
- Pharmaceutical Manufacturing
- Company size
- 1,001-5,000 employees
- Headquarters
- Dudley, Cramlington
- Type
- Privately Held
- Founded
- 1969
- Specialties
- Chiral compounds, Custom manufacturing, Fluorination, Cryogenic, Hazardous chemistry, Continuous processing and scale-up, Controlled release, API development, API manufacturing, Drug substance, Drug substance development, Drug substance manufacturing, controlled substance APIs, Potent APIs, hazardous evaluation, material science, solid state chemistry , milling, micronisation, micronization, ADCs, Antibody Drug Conjugation, Bioconjugation, HPAPI, High Potency API, and Highly Potent API
Locations
Employees at Sterling Pharma Solutions
Updates
-
Knowledge gaps, impurity synthesis and process inefficiencies are all common challenges associated with technology transfers and project scale-up. The right partner can help you overcome these challenges and maximise efficiency in your process. Click to read how: https://lnkd.in/e6Fw-WMx #CDMO #WeAreSterling
-
-
Extended Bench™ allows specialised teams to work collaboratively on different elements of a project before coming together to review progress, share insights, and maximise customer value. Want to see how it could benefit your project? Click here to read about our Extended Bench™ model in action: https://lnkd.in/eTYvAeaR #CDMO #DrugDevelopment #WeAreSterling
-
-
Flexibility, accelerated timelines and access to an international bench of scientists are just some of the advantages that our Extended Bench™ brings to our customers' projects. Want to learn more? Click here: https://lnkd.in/eqw9zvHp #CDMO #DrugDevelopment #WeAreSterling
-
Specialising in hazardous and complex chemistry, our Cramlington, UK site has been developing and manufacturing drug substances for over 50 years. Click the link to discover more and take a look at our virtual site tours. https://lnkd.in/e-D3YKfC #CDMO #DrugManufacture #WeAreSterling
-
We know that as projects evolve, requirements can change. That's why we developed our Extended Bench™ model, tailored to support your dynamic and ever-changing projects with the global resources, scientific expertise and specialist equipment your project needs, when and where it's needed. Click to explore how our Extended Bench™ could benefit your programme: https://lnkd.in/eqw9zvHp #CDMO #DrugDevelopment #WeAreSterling
-
-
R&D Group Leader, Dan Stark, discusses 'chemical process development as a foundational blueprint' in our Journey of an API blog series. Click the link in the comments to read more. #ProcessDevelopment #CDMO #DrugDevelopment #DrugManufacture #WeAreSterling
-
"Our Extended Bench™ model allows us to work on and progress different elements of our customers’ project in parallel, enabling them to better meet timelines and balance risk." Click below to read more about how Mathew Minardi, Executive Vice President of Global Project Management, and his team support our customers and oversee the allocation and planning of resources when they utilise Extended Bench™. https://lnkd.in/eZ_7PHZa #CDMO #DrugDevelopment #WeAreSterling
-
-
HPAPIs need a partner with a proven track record, click the link to read our latest case study demonstrating our experience with a complex phase I-III project. We understand that you not only need scientific support and specialist technologies, but a partner who will treat your molecule as their own. https://lnkd.in/eTSVdW22 #HPAPI #CDMO #WeAreSterling
-
-
Catch up with the latest updates from Sterling... 👥 Read about Karl Rotthier's appointment as Sterling's new CEO 🌎 Learn more about our API manufacturing facility in Cork, Ireland 🤝 Discover why it's always been about more than molecules, to you and to us 📅 Find out where you can meet the Sterling team this month Click to read the full newsletter. #CDMO #DrugDevelopment #DrugManufacture #WeAreSterling